IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 16 filers reported holding IO BIOTECH INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $25,454 | – | 13,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,277,932 | $6,408,357 | 0.50% |
| Vivo Capital, LLC | 3,015,545 | $5,895,390 | 0.41% |
| Samsara BioCapital, LLC | 1,008,437 | $1,971,494 | 0.35% |
| Avoro Capital Advisors LLC | 2,055,883 | $4,029,531 | 0.06% |
| PFM Health Sciences, LP | 612,713 | $1,197,854 | 0.05% |
| Aureus Asset Management, LLC | 43,744 | $85,520 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,200 | $259,112 | 0.01% |
| Summit Trail Advisors, LLC | 43,744 | $85,520 | 0.00% |
| Renaissance Technologies | 69,100 | $135 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,854,185 | $3,624,932 | 0.00% |